Arkansas Pediatric Clinic

Little Rock, Arkansas 72205

0 studies enrolling now · 19 studies all time

What they study most

Atopic Dermatitis, Body Weight, Congenital Heart Disease, Constipation, Growth of Term Infants, Head Lice, Healthy, Healthy Subjects, Healthy Term Infants, Influenza Vaccine, Meningococcal Vaccine, Meningococcal Vaccines

Studies at this site

• Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years — Completed
• 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis — Completed
• A Phase 2 Study to Evaluate Immune Responses of FluMist® — Completed
• Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation — Completed
• A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age — Completed
• A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17 — Completed
• A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years — Completed
• The Evaluation of Cow Milk-Based Formulas — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). — Completed
• Growth and Tolerance of Hypoallergenic Formulas — Completed
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
• Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age — Completed
• A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects — Completed
• A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease — Completed
• Growth and Tolerance of Cow Milk-Based Infant Formulas — Completed
• A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age — Stopped early
• The Evaluation of Cow's Milk Formula - Study B — Completed
• Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants — Completed